Stocksigma LogoStocksigma Logo

Astal Laboratories Board Meeting on 13th Nov'26 to Consider Q2 Results

Astal Laboratories Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the unaudited standalone and consolidated

Astal Laboratories Board Meeting on 13th Nov'26 to Consider Q2 Results

Astal Laboratories Ltd 路 Intimation 路 13 Nov 2026, 5:30 am

Astal Laboratories Board Meeting on 13th Nov'26 to Consider Q2 Results Astal Laboratories Limited has scheduled a Board of Directors meeting on 13th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th Sep'26, alongside the auditors' Limited Review Report. Additionally, pursuant to insider trading regulations, the trading window for designated persons and their immediate relatives has been closed since 1st Oct'26 and will remain shut until 48 hours following the conclusion of the board meeting.

Original exchange filing (PDF)

More announcements from Astal Laboratories Ltd

All Astal Laboratories Ltd announcements